Showing 3251-3260 of 8791 results for "".
The Corneal Sweep Test and Recurrent Corneal Erosions
https://crstoday.com/topics/cataract-surgery/the-corneal-sweep-test-and-recurrent-corneal-erosions/44593/A diagnostic technique for classification of a difficult-to-diagnose condition.Low-Level Light Therapy
https://crstoday.com/topics/cornea/low-level-light-therapy/44486/This procedure is a simple and effective option for treating meibomian gland dysfunction.Update on Surface Ablation Procedures: Part One
https://crstoday.com/topics/general/update-on-surface-ablation-procedures-part-one/42139/Six Keys for Clearer Posterior Capsules
https://crstoday.com/crst-issues/2002-mar/0302_12-html/40206/Significant advances in the struggle to eliminate PCO.The First-line Advantages of SLT
https://crstoday.com/crst-supplements/the-first-line-advantage-of-slt/the-first-line-advantages-of-slt/43595/SLT can lower IOP, reduce medication use, and provide key diagnostic information.Point/Counterpoint: Is Corneal Thickness a Risk Factor for Post-LASIK Ectasia?
https://crstoday.com/topics/general/crst0907_08-php/41167/CENTRAL CORNEAL THICKNESS AS A PRE-LASIK CONSIDERATION.Success Rates of Combined Phacotrabeculectomies Versus Separately Performed Procedures
https://crstoday.com/topics/general/success-rates-of-combined-phacotrabeculectomies-versus-separately-performed-procedures/41844/Known Risk Factors for Ectasia
https://crstoday.com/crst-issues/2005-oct/crst1005_19-php/40698/What do we know so far?Newly Approved Glaucoma Therapy Increases Options for Patients and Providers
https://crstoday.com/topics/comorbidities/newly-approved-glaucoma-therapy-increases-options-for-patients-and-providers/43625/Netarsudil, a ROCK inhibitor, represents the first novel class of IOP-lowering medications to reach the glaucoma market since the 1990s.The Literature
https://crstoday.com/topics/general/the-literature-2/42638/